Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

1.

SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder.

Rinne T, van den Brink W, Wouters L, van Dyck R.

Am J Psychiatry. 2002 Dec;159(12):2048-54.

PMID:
12450955
[PubMed - indexed for MEDLINE]
2.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
[PubMed - indexed for MEDLINE]
3.

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.

Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB.

Am J Psychiatry. 2005 Mar;162(3):621-4.

PMID:
15741486
[PubMed - indexed for MEDLINE]
4.

A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

Zanarini MC, Frankenburg FR, Parachini EA.

J Clin Psychiatry. 2004 Jul;65(7):903-7.

PMID:
15291677
[PubMed - indexed for MEDLINE]
5.

Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Vielma W, Montes C, Pumarino L, Roa N.

Actas Esp Psiquiatr. 2007 Nov-Dec;35(6):387-92.

PMID:
17597424
[PubMed - indexed for MEDLINE]
6.

Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.

Linehan MM, McDavid JD, Brown MZ, Sayrs JH, Gallop RJ.

J Clin Psychiatry. 2008 Jun;69(6):999-1005.

PMID:
18466045
[PubMed - indexed for MEDLINE]
7.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
[PubMed - indexed for MEDLINE]
8.

Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?

Abraham PF, Calabrese JR.

J Affect Disord. 2008 Nov;111(1):21-30. doi: 10.1016/j.jad.2008.01.024. Epub 2008 Mar 4. Review.

PMID:
18304647
[PubMed - indexed for MEDLINE]
9.

A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response.

Pearlstein T, Spurell E, Hohlstein LA, Gurney V, Read J, Fuchs C, Keller MB.

Arch Womens Ment Health. 2003 Apr;6(2):147-51.

PMID:
12720065
[PubMed - indexed for MEDLINE]
10.

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.

Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C.

Biol Psychiatry. 2000 May 1;47(9):813-7.

PMID:
10812040
[PubMed - indexed for MEDLINE]
11.

Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.

Goodman WK, Kozak MJ, Liebowitz M, White KL.

Int Clin Psychopharmacol. 1996 Mar;11(1):21-9.

PMID:
8732310
[PubMed - indexed for MEDLINE]
12.

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.

Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW.

Psychiatry Res. 2001 Aug 5;103(1):1-14.

PMID:
11472786
[PubMed - indexed for MEDLINE]
13.

Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.

Pascual JC, Soler J, Puigdemont D, Pérez-Egea R, Tiana T, Alvarez E, Pérez V.

J Clin Psychiatry. 2008 Apr;69(4):603-8.

PMID:
18251623
[PubMed - indexed for MEDLINE]
14.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
[PubMed - indexed for MEDLINE]
15.

An open trial of valproate in borderline personality disorder.

Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.

J Clin Psychiatry. 1995 Nov;56(11):506-10.

PMID:
7592502
[PubMed - indexed for MEDLINE]
16.

[Fluoxetine in the treatment of borderline personality disorder].

Silva H, Jerez S, Paredes A, Salvo J, Rentería P, Ramírez A, Montes C.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Spanish.

PMID:
9477607
[PubMed - indexed for MEDLINE]
17.

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.

Zanarini MC, Frankenburg FR.

Am J Psychiatry. 2003 Jan;160(1):167-9.

PMID:
12505817
[PubMed - indexed for MEDLINE]
18.

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH.

Arch Gen Psychiatry. 1996 Nov;53(11):1001-8.

PMID:
8911223
[PubMed - indexed for MEDLINE]
19.

[Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].

Fukuda T, Sugie H, Ito M, Sugie Y.

No To Hattatsu. 2001 Jul;33(4):314-8. Japanese.

PMID:
11494573
[PubMed - indexed for MEDLINE]
20.

[Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].

Sugie Y, Sugie H, Fukuda T, Ito M, Ohzeki T.

No To Hattatsu. 2003 Jan;35(1):23-8. Japanese.

PMID:
12607287
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk